World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
98
Citations
73628
World Ranking
8722
National Ranking
4497

Edwin R. Fisher publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Edwin R. Fisher sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 419 publications — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Edwin R. Fisher D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Edwin R. Fisher sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 98 D-Index — 57th percentile

57% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Edwin R. Fisher is affiliated with the University of Pittsburgh in the United States. Their research contributions primarily focus on the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with specific attention to Cancer Research, Oncology, and Pulmonary and Respiratory Medicine.

The scientist's work covers multiple topics within cancer treatment and management. These include:

  • Breast Cancer Treatment Studies
  • Colorectal Cancer Surgical Treatments
  • Gastric Cancer Management and Outcomes

Edwin R. Fisher has published in notable venues, with known contributions appearing in:

  • Journal of Clinical Oncology

One of their recent papers is titled "Effect of preoperative chemotherapy on the outcome of women with operable breast cancer," published in 2023 in the Journal of Clinical Oncology. This work has been cited 143 times, indicating engagement within the oncology research community.

Frequent collaborative relationships have been established with several researchers, including:

  • Bernard Fisher
  • John Bryant
  • Norman Wolmark
  • E.P. Mamounas
  • A Brown

The combination of these collaborations, publication venues, and research topics illustrates a focus on cancer-related clinical and biological studies, particularly in breast cancer and gastrointestinal cancers.

Best Publications

  • Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.

    Bernard Fisher;Stewart Anderson;John Bryant;Richard G Margolese

  • A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer

    Soonmyung Paik;Steven Shak;Gong Tang;Chungyeul Kim

  • Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.

    B Fisher;J Bryant;N Wolmark;E Mamounas

  • Five-Year Results of a Randomized Clinical Trial Comparing Total Mastectomy and Segmental Mastectomy with or without Radiation in the Treatment of Breast Cancer

    B Fisher;M Bauer;R Margolese;R Poisson

  • Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18.

    B Fisher;A Brown;E Mamounas;S Wieand

  • Eight-Year Results of a Randomized Clinical Trial Comparing Total Mastectomy and Lumpectomy with or without Irradiation in the Treatment of Breast Cancer

    B Fisher;C Redmond;R Poisson;R Margolese

  • Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation

    B Fisher;C Redmond;E R Fisher;M Bauer

  • A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive Tumors

    Fisher B;Costantino J;Redmond C;Poisson R

  • Endometrial Cancer in Tamoxifen-Treated Breast Cancer Patients: Findings From the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14

    Fisher B;Costantino Jp;Redmond Ck;Fisher Er

  • Twenty-Five-Year Follow-up of a Randomized Trial Comparing Radical Mastectomy, Total Mastectomy, and Total Mastectomy Followed by Irradiation

    Bernard Fisher;Jong-Hyeon Jeong;Stewart Anderson;John Bryant

  • Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01.

    Bernard Fisher;Norman Wolmark;Howard Rockette;Carol Redmond

  • Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update.

    Bernard Fisher;Madeline Bauer;D. Lawrence Wickerham;Carol K. Redmond

  • Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial

    Bernard Fisher;James Dignam;Norman Wolmark;D Lawrence Wickerham

  • Pathologic findings from the National Surgical Adjuvant Breast Project (protocol 6). I. Intraductal carcinoma (DCIS).

    Edwin R. Fisher;Richard Sass;Bernard Fisher;Lawrence Wickerham

  • Lumpectomy Compared with Lumpectomy and Radiation Therapy for the Treatment of Intraductal Breast Cancer

    B Fisher;J Costantino;C Redmond;E Fisher

  • Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-17

    B. Fisher;J. Dignam;N. Wolmark;E. Mamounas

  • Five Versus More Than Five Years of Tamoxifen Therapy for Breast Cancer Patients With Negative Lymph Nodes and Estrogen Receptor-Positive Tumors

    Bernard Fisher;James Dignam;John Bryant;Arthur DeCillis

  • The pathology of invasive breast cancer. A syllabus derived from findings of the National Surgical Adjuvant Breast Project (protocol no. 4).

    Edwin R. Fisher;Remigio M. Gregorio;Bernard Fisher;Frank Vellios

  • 1-Phenylalanine mustard (L-PAM) in the management of primary breast cancer. A report of early findings.

    Bernard Fisher;Paul Carbone;Steven G. Economou;Robert Frelick

  • The Benefit of Leucovorin-Modulated Fluorouracil as Postoperative Adjuvant Therapy for Primary Colon Cancer: Results From National Surgical Adjuvant Breast and Bowel Project Protocol C-03

    N Wolmark;H Rockette;B Fisher;D L Wickerham

Frequent Co-Authors

Bernard Fisher
Bernard Fisher University of Pittsburgh
Norman Wolmark
Norman Wolmark University of Pittsburgh
Joseph P. Costantino
Joseph P. Costantino University of Pittsburgh
Eleftherios P. Mamounas
Eleftherios P. Mamounas University of Florida Health
Soonmyung Paik
Soonmyung Paik Yonsei University
Mark C. Gebhardt
Mark C. Gebhardt Harvard Medical School
Sofia D. Merajver
Sofia D. Merajver University of Michigan–Ann Arbor
Bruce A. Barton
Bruce A. Barton University of Massachusetts Chan Medical School
Nicholas J. Petrelli
Nicholas J. Petrelli Christiana Care Health System
Bruce A. Chabner
Bruce A. Chabner Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Medicine opens doors to many related fields, especially for those interested in healthcare but seeking flexible study options. Online nursing degrees are a popular pathway, offering convenience and accessibility for busy students or working professionals. Online programs also tend to provide a wider range of affordable options.

If you're searching for advanced practice roles, consider the cheapest dnp online program options, which can help you become a leader in nursing. For registered nurses looking to advance their qualifications, finding what is the cheapest rn to bsn program online can make your education more accessible without compromising quality.

Those without a nursing background may benefit from online direct entry msn programs for non-nursing majors, designed to fast-track your entry into the nursing profession. Additionally, if you are considering the quickest or more accessible pathways, you might want to research the easiest rn program options available online.

With the growing demand for qualified healthcare professionals, online degrees provide flexible and affordable routes to a fulfilling medical career.

Best Scientists Citing Edwin R. Fisher

Trending Scientists

Recently Published Articles